Detalhe da pesquisa
1.
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR).
Eur Respir J
; 61(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229048
2.
Hyperhaemolysis caused by anti-HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion.
Transfus Med
; 33(4): 349-351, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37186414
3.
The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper.
Br J Haematol
; 198(3): 459-477, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35661144
4.
Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model.
Bioorg Med Chem Lett
; 27(12): 2683-2688, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28465103
5.
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice.
Bioorg Med Chem Lett
; 27(10): 2087-2093, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389149
6.
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
Bioorg Med Chem Lett
; 26(4): 1260-4, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26810316
7.
Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
Br J Haematol
; 189(1): 24-38, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31991476
8.
Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria.
Blood
; 121(14): 2753-61, 2013 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23372165
9.
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic.
J Med Chem
; 67(5): 3935-3958, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365209
10.
Lessons learned from a review of paroxysmal nocturnal haemoglobinuria (PNH) requests: a report from the UK PNH Network.
Br J Haematol
; 182(6): 930-933, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857128
11.
The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.
Br J Haematol
; 162(3): 400-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23713628
12.
Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia.
J Med Chem
; 66(2): 1157-1171, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624931
13.
Structural connectivity mediates the relationship between blood oxygenation and cognitive function in sickle cell anemia.
Blood Adv
; 7(11): 2297-2308, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947137
14.
Clinical performance validation of the STANDARD G6PD test: A multi-country pooled analysis.
PLoS Negl Trop Dis
; 17(10): e0011652, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37824592
15.
Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine.
Ann Rheum Dis
; 71(10): 1630-5, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22966146
16.
Individual Watershed Areas in Sickle Cell Anemia: An Arterial Spin Labeling Study.
Front Physiol
; 13: 865391, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35592036
17.
Quantification of Silent Cerebral Infarction on High-Resolution FLAIR and Cognition in Sickle Cell Anemia.
Front Neurol
; 13: 867329, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847220
18.
Venous cerebral blood flow quantification and cognition in patients with sickle cell anemia.
J Cereb Blood Flow Metab
; 42(6): 1061-1077, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986673
19.
Association of respiratory failure with inhibition of NaV1.6 in the phrenic nerve.
Channels (Austin)
; 16(1): 230-243, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239534
20.
Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate.
Arthritis Rheum
; 62(11): 3154-60, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20662070